Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 41(6): 539-543, June 2008. ilus, tab
Article Dans Anglais | LILACS | ID: lil-485848

Résumé

Gastric cancer is the forth most frequent malignancy and the second most common cause of cancer death worldwide. DNA methylation is the most studied epigenetic alteration, occurring through a methyl radical addition to the cytosine base adjacent to guanine. Many tumor genes are inactivated by DNA methylation in gastric cancer. We evaluated the DNA methylation status of ANAPC1, CDKN2A and TP53 by methylation-specific PCR in 20 diffuse- and 26 intestinal-type gastric cancer samples and 20 normal gastric mucosa in individuals from Northern Brazil. All gastric cancer samples were advanced stage adenocarcinomas. Gastric samples were surgically obtained at the João de Barros Barreto University Hospital, State of Pará, and were stored at -80°C before DNA extraction. Patients had never been submitted to chemotherapy or radiotherapy, nor did they have any other diagnosed cancer. None of the gastric cancer samples presented methylated DNA sequences for ANAPC1 and TP53. CDKN2A methylation was not detected in any normal gastric mucosa; however, the CDKN2A promoter was methylated in 30.4 percent of gastric cancer samples, with 35 percent methylation in diffuse-type and 26.9 percent in intestinal-type cancers. CDKN2A methylation was associated with the carcinogenesis process for ~30 percent diffuse-type and intestinal-type compared to non-neoplastic samples. Thus, ANAPC1 and TP53 methylation was probably not implicated in gastric carcinogenesis in our samples. CDKN2A can be implicated in the carcinogenesis process of only a subset of gastric neoplasias.


Sujets)
Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Adénocarcinome/génétique , Méthylation de l'ADN/génétique , Tumeurs de l'estomac/génétique , Ubiquitin-protein ligase complexes/métabolisme , Adénocarcinome/métabolisme , Adénocarcinome/anatomopathologie , Études cas-témoins , Réaction de polymérisation en chaîne , Régions promotrices (génétique)/génétique , Tumeurs de l'estomac/métabolisme , Tumeurs de l'estomac/anatomopathologie
2.
Braz. j. med. biol. res ; 37(12): 1831-1838, Dec. 2004. ilus, tab
Article Dans Anglais | LILACS | ID: lil-388056

Résumé

Gastric cancer is the second most frequent type of neoplasia and also the second most important cause of death in the world. Virtually all the established cell lines of gastric neoplasia were developed in Asian countries, and western countries have contributed very little to this area. In the present study we describe the establishment of the cell line ACP01 and characterize it cytogenetically by means of in vitro immortalization. Cells were transformed from an intestinal-type gastric adenocarcinoma (T4N2M0) originating from a 48-year-old male patient. This is the first gastric adenocarcinoma cell line established in Brazil. The most powerful application of the cell line ACP01 is in the assessment of cytotoxicity. Solid tumor cell lines from different origins have been treated with several conventional and investigational anticancer drugs. The ACP01 cell line is triploid, grows as a single, non-organized layer, similar to fibroblasts, with focus formation, heterogeneous division, and a cell cycle of approximately 40 h. Chromosome 8 trisomy, present in 60 percent of the cells, was the most frequent cytogenetic alteration. These data lead us to propose a multifactorial triggering of gastric cancer which evolves over multiple stages involving progressive genetic changes and clonal expansion.


Sujets)
Humains , Mâle , Adulte d'âge moyen , Adénocarcinome/génétique , Lignée cellulaire tumorale , Analyse cytogénétique/méthodes , Tumeurs de l'estomac/génétique , Adénocarcinome/anatomopathologie , Clones cellulaires , Cryoconservation , Lignée cellulaire tumorale/anatomopathologie , Caryotypage , Tumeurs de l'estomac/anatomopathologie , Trisomie/génétique , Trisomie/anatomopathologie
SÉLECTION CITATIONS
Détails de la recherche